Acotec Scientific Holdings Limited (06669.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 6.19

From 52W high−60.54%

Volume465000.00

Market capHKD 1.78B

P/E (TTM)—

P/S (TTM)2.4x

Div yield—

Key dataSep 18, 2026

Open

HKD 6.19

From 52W high

−60.54%

Volume

465000.00

Market cap

HKD 1.78B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−34.3x

P/E (TTM)

—

RSI (14)

37.1

MomentumView details →

1D Return

−4.07%

YTD Return

−56.30%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−34.3x

EV/Sales

1.5x

P/S (TTM)

2.4x

P/B (TTM)

1.1x

ProfitabilityView details →

Gross Margin

71.84%

Net Margin

−8.04%

EBITDA Margin

−4.24%

ROE (TTM)

−3.60%

ROA (TTM)

−2.82%

Asset Turnover

0.35x

GrowthView details →

Revenue YoY

+5.42%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+17.68%

EPS CAGR 3Y

+19.25%

EBITDA YoY

—

MomentumView details →

1D Return

−4.07%

YTD Return

−56.30%

1Y Return

−55.64%

RSI (14)

37.1

vs 50D SMA

−15.98%

vs 200D SMA

−43.24%

Capital & dividendView details →

Debt/Equity

0.14x

Current Ratio

5.40x

Quick Ratio

4.73x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−HKD 0.31

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

HKD 0.00

Avg Surprise (4Q)

—

Rev Surprise

115.83%

Financials snapshotView financials →

Revenue (TTM)

625.00M

Net Income (TTM)

−50.23M

Op. CF (TTM)

8.41M

Next earningsMar 29, 2027 →

Latest newsMore news →

Acotec Medical reported an interim net loss of 80.83 million RMB for the six months ended June 2026, swinging from a profit of 88.58 million RMB a year earlier, with revenue down 5.6% to 332 million RMB.20d ago

Acotec Scientific (06669.HK) issued a profit warning, expecting a net loss of not more than 80.9 million RMB for the six months ended June 30, 2026, compared with a profit of 88.6 million RMB in the same period last year, mainly due to non-cash impairment losses and expense provisions of approximately 151 million RMB arising from the termination of the US clinical trial project.39d ago

Similar companies

Alphatec Holdings, Inc.ATEC Shanghai HeartCare Medical Technology Corporation Limited06609.HK 奥精医疗688613.SH Establishment Labs Holdings Inc.ESTA Butterfly Network, Inc.BFLY UFP Technologies, Inc.UFPT Find similar companies →

Latest newsMore news →

Acotec Medical reported an interim net loss of 80.83 million RMB for the six months ended June 2026, swinging from a profit of 88.58 million RMB a year earlier, with revenue down 5.6% to 332 million RMB.20d ago Acotec Scientific (06669.HK) issued a profit warning, expecting a net loss of not more than 80.9 million RMB for the six months ended June 30, 2026, compared with a profit of 88.6 million RMB in the same period last year, mainly due to non-cash impairment losses and expense provisions of approximately 151 million RMB arising from the termination of the US clinical trial project.39d ago